We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-8 of 8

BaFin decrees on short selling enacted on May 18, 2010

  • Sidley Austin LLP
  • -
  • Germany
  • -
  • May 21 2010

On May 18, 2010 the German Federal Financial Services Supervisory Authority (Bundesanstalt für Finanzdienstleistungsaufsicht - "BaFin") published three general decrees (Allgemeinverfügung) banning (a) "naked short sales" (as defined below) of shares in ten specifically named German financial enterprises, (b) naked short sales of government bonds of the Member States of the Eurozone and (c) naked CDS relating to government bonds of the Member States of the Eurozone

Risk of seizure by German public prosecutors (Staatsanwaltschaften) of interview protocols produced in internal investigations

  • Sidley Austin LLP
  • -
  • Germany
  • -
  • April 25 2011

In a published decision (608 Qs 1810, dated October, 15, 2010) the District Court of Hamburg upheld the seizure by the public prosecutions authorities of Hamburg of interview protocols prepared for the purposes of an internal investigation by the law firm Freshfields Bruckhaus Deringer (the "Law Firm"

New German notification and publication requirements for net short positions from 26 March 2012

  • Sidley Austin LLP
  • -
  • Germany
  • -
  • March 23 2012

Section 30i of the German Securities Trading Act becomes effective on 26 March 2012, and maintains the existing two-tier transparency system of BaFin’s General Decree dated 4 March 2010

Updates on international pricing issues for pharmaceutical and biologic products

  • Sidley Austin LLP
  • -
  • China, European Union, France, Germany, United Kingdom, USA
  • -
  • May 18 2012

Sidley Austin LLP’s Global Life Sciences Team is pleased to provide you with this Global Pricing Newsletter, the first in a periodic series updating clients and friends of the firm on pricing issues around the world that may have an impact on pharmaceutical and biologic manufacturers’ legal and business strategies

Stricter interpretation of Safe Harbor principles by German data protection authorities (due diligence requirements)

  • Sidley Austin LLP
  • -
  • Germany, USA
  • -
  • June 22 2010

German data protection authorities have placed a significant new duty on German companies transferring personal data to US companies on the basis of the Safe Harbor principles to inquire into the compliance practices of the US Safe Harbor member

Heraeus Kulzer GmbH v. Biomet, Inc., 633 F.3d 591 (7th Cir. Jan. 24, 2011)

  • Sidley Austin LLP
  • -
  • Germany, USA
  • -
  • May 5 2011

The Seventh Circuit ruled that petitioner Heraeus Kulzer was entitled to obtain discovery in the United States pursuant to 28 U.S.C. 1782 in support of its trade secret lawsuit against Biomet in German court

Adoption of OECD’s authorized functionally separate entity approach into German tax law

  • Sidley Austin LLP
  • -
  • Germany
  • -
  • March 8 2012

It is expected that, with effect from January 1, 2013, Germany will adopt the OECD’s authorized functionally separate entity approach to the attribution of profits to permanent establishments

Refund of German withholding taxes on dividends for foreign investors holding stakes of less than 10 in German corporations

  • Sidley Austin LLP
  • -
  • European Union, Germany
  • -
  • August 14 2012

Under the domestic German corporate income tax regime, dividend distributions are subject to deduction on account of German withholding tax at a rate of 25